Evaluation of quality of clinical management of neuroendocrine tumors-Reference-Cited by-同舟云学术

Evaluation of quality of clinical management of neuroendocrine tumors

Published:2022-12 Issue:4 Volume:1 Page:305-315
ISSN:2770-9183
Container-title:Cancer Innovation
language:en
Short-container-title:Cancer Innovation

Author:

Bloemen Hannah¹^ORCID,Kneepkens Kristien¹,Deraedt Karen²,Ivanova Anna¹,Sergeant Gregory¹³,Mebis Jeroen¹⁴,Van der Speeten Kurt¹⁵

Affiliation:

1. Department of Medicine, Faculty of Medicine and Life Sciences (LCRC) Hasselt University Diepenbeek Belgium

2. Department of Pathology and Department Future Health Ziekenhuis Oost‐Limburg Genk Belgium

3. Department of Abdominal Surgery and Department Jessa & Science Jessa Hospital Hasselt Belgium

4. Department of Medical Oncology and Department Jessa & Science Jessa Hospital Hasselt Belgium

5. Department of Surgical Oncology and Department Future Health Ziekenhuis Oost‐Limburg Genk Belgium

Funder

Novartis

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cai2.41

Reference48 articles.

1. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

2. Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes

3. StordeurS VrijensF HenauK SchillemansV De GendtCLR. Organisation of care for adults with a rare or complex cancer. 2014. Heal. Serv. Res. Brussels Belgian Heal. Care Knowl. Cent. D/2014/10.(KCE Reports 219) (2014).

4. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies*

5. ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms